RxFunction’s walk2wellness study has added Johns Hopkins in Baltimore Maryland as its fifth site for its ongoing clinical trial of its Walkasins Lower Limb Sensory Neuroprosthesis. The study is designed to assess Walkasins’ use on peripheral neuropathy patients at high-fall risk. Patients may now enroll at Johns Hopkins in Baltimore, as well as other study sites. RxFunction has provided information here for patients who would like to know more about the study. Alternatively, interested patients can read about the study here on www.clinicaltrials.gov as well as find contact information for the study. More information can also be found on the RxFunction website here.
Menu